Axatilimab in combination with ruxolitinib in patients with newly diagnosed chronic graft-versus-host disease: interim safety analysis of a phase 2, randomized study

Poster Presentation | Dec 6, 2025

Author

Zeiser R, et al.

Congress

American Society of Hematology Annual Meeting 2025

Orlando, Florida | Dec 6 – 9, 2025